Meeting abstract
https://doi.org/10.33004/reumatizam-supp-73-1-11
From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis
Rifat Međerović
*
* Corresponding author.
Full text: croatian pdf 1.032 Kb
page 16-16
downloads: 0
cite
APA 6th Edition
Međerović, R. (2026). From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis. Reumatizam, 73 (Supp 1), 16-16. https://doi.org/10.33004/reumatizam-supp-73-1-11
MLA 8th Edition
Međerović, Rifat. "From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis." Reumatizam, vol. 73, no. Supp 1, 2026, pp. 16-16. https://doi.org/10.33004/reumatizam-supp-73-1-11. Accessed 4 Nov. 2026.
Chicago 17th Edition
Međerović, Rifat. "From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis." Reumatizam 73, no. Supp 1 (2026): 16-16. https://doi.org/10.33004/reumatizam-supp-73-1-11
Harvard
Međerović, R. (2026). 'From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis', Reumatizam, 73(Supp 1), pp. 16-16. https://doi.org/10.33004/reumatizam-supp-73-1-11
Vancouver
Međerović R. From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis. Reumatizam [Internet]. 2026 [cited 2026 November 04];73(Supp 1):16-16. https://doi.org/10.33004/reumatizam-supp-73-1-11
IEEE
R. Međerović, "From pathogenesis to targeted therapy: new perspectives in polymyalgia rheumatica and giant cell arteritis", Reumatizam, vol.73, no. Supp 1, pp. 16-16, 2026. [Online]. https://doi.org/10.33004/reumatizam-supp-73-1-11
Abstract
Keywords
polymyalgia rheumatica, giant cell arteritis, interleukin-6, JAK inhibitors
Hrčak ID:
352644
URI
https://hrcak.srce.hr/352644
Publication date:
21.10.2026.
Article data in other languages:
croatian
Visits: 0
*